CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
Accession: CHEBI:76840
browse the term
Definition: An EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of any enzyme in the EC 1.14.99.* (miscellaneous) category.
Synonyms: related_synonym: EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitors; EC 1.14.99.* inhibitor; EC 1.14.99.* inhibitors
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Aspirin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Antipyrine results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
carprofen results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
CYP2C41
cytochrome P450 2C41
affects metabolic processing increases hydroxylation
EXP
CYP2C9 protein affects the metabolism of Diclofenac CYP2C19 protein results in increased hydroxylation of Diclofenac
CTD
PMID:15677349 PMID:15801540
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Diclofenac results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
Etodolac results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
CPNE6
copine 6
decreases activity
EXP
Flufenamic Acid results in decreased activity of DHRS4 protein
CTD
PMID:17827741
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Ibuprofen results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Ibuprofen results in increased expression of PTGS2 protein
CTD
PMID:16105799
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
HEXB
hexosaminidase subunit beta
multiple interactions
EXP
Indomethacin promotes the reaction [mastoparan results in increased secretion of HEXB protein]
CTD
PMID:21671308
NCBI chr 2:57,221,809...57,248,432
Ensembl chr 2:57,222,186...57,248,417
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Indomethacin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Dipyrone results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
IL1B
interleukin 1 beta
decreases expression
EXP
nimesulide results in decreased expression of IL1B mRNA
CTD
PMID:19638440
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
nimesulide results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 mRNA; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 protein
CTD
PMID:12857884 PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
decreases localization
EXP
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased localization of RELA protein
CTD
PMID:12857884
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Acetaminophen results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
UGT1A6
UDP glucuronosyltransferase 1 family, polypeptide A6
increases glucuronidation
EXP
UGT1A6 protein results in increased glucuronidation of Acetaminophen
CTD
PMID:11903872
NCBI chr25:45,081,655...45,161,584
Ensembl chr25:45,032,130...45,160,941
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
affects metabolic processing
EXP
CYP1A2 protein affects the metabolism of Phenacetin
CTD
PMID:15801540
NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases activity
EXP
Phenacetin results in decreased activity of PTGS1 protein alternative form
CTD
PMID:12242329
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
Sulindac results in decreased expression of PTGS2 protein
CTD
PMID:12857884
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
decreases localization
EXP
Sulindac results in decreased localization of RELA protein
CTD
PMID:12857884
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
tolfenamic acid results in decreased expression of PTGS2 mRNA
CTD
PMID:15198222
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all